Why switch from warfarin to NOACs?
Crossref DOI link: https://doi.org/10.1007/s11739-016-1411-0
Published Online: 2016-03-14
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verdecchia, Paolo
Angeli, Fabio
Aita, Adolfo
Bartolini, Claudia
Reboldi, Gianpaolo
Funding for this research was provided by:
Fondazione Umbra Cuore e Ipertensione-ONLUS
Text and Data Mining valid from 2016-03-14